007) and a trend towards smaller infarct core volumes (18 ml vs 34 ml, p = 0.15) at baseline. TCD monitoring times were not significantly different between groups (major reperfusion, 103 min; non-reperfusion, 124 min; p = 0.34). Consistent with other studies, patients with major reperfusion showed smaller median 24 h infarct

core volumes (28 ml vs 46 ml, p = 0.005), lower 24 h mean NIHSS score (12.1 vs 16.7, p = 0.009), and a higher proportion of patients with favourable 90 day functional outcomes (mRS 0–2, 63% vs 10%, p = 0.002). The TIBI grade profiles for each case is shown in Fig. 1A and B. Major TIBI grade change (improvement by ≥3 grades during the post-thrombolysis monitoring period) was associated with major reperfusion (p = 0.04) GSI-IX order along with higher odds of attenuation of infarct core growth (p = 0.06), improvement in NIHSS score (p = 0.049) and excellent 90 day functional outcome (mRS 0–1; p = 0.03). Major sudden TIBI grade change (improvement of ≥3 grades over ≤15 min) was associated with a trend towards excellent functional outcome (mRS

0–1; p = 0.09). MES were detected in 36% proportion of cases overall, 37% in the patients with major reperfusion and 33% in patients with non-reperfusion (p = 0.55). There was no association between the presence of microemboli and major Veliparib cost TIBI grade change, 24 h infarct core volume or clinical outcomes. This is the first description of the relationship between TCD features of leptomeningeal

collateralisation and recanalization, hyperacute Cyclin-dependent kinase 3 brain perfusion status, and their relationships to tissue fate and clinical outcomes in acute ischemic stroke. Our data demonstrate that the ACA FD is associated with improved LMC and is independently associated with 24 h infarct volume and 90 day clinical outcome in acute anterior circulation stroke patients with identifiable large artery occlusion. ACA FD may therefore define a group of patients who have a greater tolerance to ICA or MCA occlusion and, potentially, a longer-lived ischemic penumbra. Our data also demonstrate that in MCA occlusion patients treated with intravenous thrombolysis, major improvement in TIBI grade is associated with major reperfusion at 24 h along with improved 24 h and 90 day clinical outcome and a trend towards less infarct core growth. Although definitions and indices of ACA flow diversion vary in the literature [17], [20], [21], [22] and [23] the ACA asymmetry index used by Zanette [20], based on comparison between digital cerebral angiography and TCD performed within 6 h of stroke onset, is likely to be the most reliable and easily applicable measure in hyperacute stroke. The same asymmetry index was used to define TCD FD in the retrospective analysis of the CLOTBUST trial. In this study, FD was observed in 83% of patients with MCAO treated with tissue plasminogen activator therapy.